Retour
Prix ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (01541.HK)
Graphique du cours de l'action 01541.HK
IMMUNEONCO-B (01541.HK)
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
HK$4.75
-11.71%
$-0.62
Pause déjeuner: Jan 21, 12:00:00 HKT
Pas encore de donnéesFollow-Up Questions
Quels sont les états financiers clés de ImmuneOnco Biopharmaceuticals (Shanghai) Inc. ?
Quels sont les ratios financiers clés pour 01541.HK ?
Comment les revenus de ImmuneOnco Biopharmaceuticals (Shanghai) Inc. sont-ils répartis par segment ou géographie ?
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. est-elle rentable ?
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. a-t-elle des passifs ?
Combien d'actions en circulation ImmuneOnco Biopharmaceuticals (Shanghai) Inc. a-t-elle ?
Statistiques clés
Clôture préc.
$5.38
Prix d'ouverture
$5.38
Plage de la journée
$4.73 - $5.39
Plage de 52 semaines
$4.31 - $16.8
Volume
3.2M
Volume moyen
2.1M
BPA (TTM)
-0.93
Rendement en dividend
--
Capitalisation boursière
$1.9B
Qu’est-ce que IMMUNEONCO-B ?
ImmuneOnco Biopharmaceuticals (Shanghai), Inc. operates as an early-stage biopharmaceutical company which develops and commercializes novel cancer immunotherapeutic products. The company is headquartered in Shanghai, Shanghai and currently employs 195 full-time employees. The company went IPO on 2023-09-05. The firm's main businesses include the development of biotechnology for the systemic utilization of innate and adaptive immunity, and the development of next-generation tumor immunotherapies, which primarily focus on the adaptive immune system. The firm's core product IMM01 is an innovative CD47-targeted molecule. The firm mainly operates its businesses in the domestic and overseas markets.
Fonctionnalités
Stratégies de trading
Ressources
© 2025 Finture Development Limited. All rights reserved